Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score<sup>®</sup> test among node-negative early breast cancer patients in Japan. [PDF]
Breast CancerKoizumi K +13 more
europepmc +1 more source
Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China. [PDF]
Regen TherShi J, Hu H, Ung COL.
europepmc +1 more source
Addressing the gaps in heart failure treatment for frail older adults: challenges, evidence, and future directions. [PDF]
ESC Heart FailMyrstad M, Skaar E, Myhre PL.
europepmc +1 more source
Finding value in the third year of cardiology fellowship in the new age of an accelerated pathway to electrophysiology. [PDF]
HeartRhythm Case RepHaloot J.
europepmc +1 more source
Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab. [PDF]
Lancet Reg Health EurGuizzaro L +10 more
europepmc +1 more source
Methodological Requirements Regarding Quality of Life Measurement in the Early Assessment of Benefit In Germany [PDF]
Value in Health, 2014 Blome, C., Augustin, M., Lohrberg, D.
openaire +2 more sources
Perioperative circulating tumor DNA profiling for recurrence risk in esophageal squamous cell carcinoma: moving toward a biology-driven surveillance model. [PDF]
Ann Transl MedKlacking E, Ma W.
europepmc +1 more source
Development and validation of a nomogram for predicting early rupture and rebleeding risk after intracranial aneurysm embolization. [PDF]
Front NeurolDu P, Yu F, Chen G, Xu W.
europepmc +1 more source
Early norepinephrine in septic shock: are we treating physiology or system efficiency? [PDF]
Crit CarePrakash J, Priye S.
europepmc +1 more source
PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011 [PDF]
Value in Health, 2012 openaire +1 more source